
Reckitt Benckiser (RB) has announced that its £105 million research and development facility in the UK city of Hull – …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

